Why ACRS? Aclaris Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
ACRS
$4.53+0.12 (+2.72%)
Market ClosedLast close May 4
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.